RETATRUTIDE

30 MG

$175.00

TRIPLE AGONIST, Activating GLP, GIP, and GLUCAGON receptors, Lipid Metabolism, Energy Expenditure, Weight regulation.

57 units available

Quantity

View Cart

Latest Lab Status

No laboratory record published yet.

Product Information

Documentation

Retatrutide is an experimental peptide within the incretin class, acting as a triple agonist of the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and GCGR (glucagon) receptors. Within experimental protocols, this molecule is studied for its unprecedented synergistic impact on insulin regulation, energy expenditure, and lipid oxidation

Batch Documentation

Laboratory Results

View Lab Database →

No laboratory records available for this product.

Product Information Notice

Product information is provided for catalogue documentation and research-reference purposes.